Cardinal Health entered into a binding letter of intent to extend its existing pharmaceutical distribution agreement with CVS Health through June 30, 2032. The extension reflects the continuation of Cardinal Health's current scope of distribution services for the pharmacy benefit manager. In connection with this announcement, the company reaffirmed its fiscal year 2027 non-GAAP earnings per share guidance range of $12.40 to $12.60 and its long-term non-GAAP EPS growth rate guidance of 12% to 14%. Cardinal Health is a distributor of pharmaceuticals and specialty products, as well as a global manufacturer and distributor of medical and laboratory products.
